Monophasic HA dermal filler for deep dermis / subcutaneous volumising (contouring)
Certifications
CE certified (manufacturer brochure explicitly states CE certification for the TEOFIL family; brochure indicates compliance with medical device regulations for CE marking).
Manufacturer states ISO 13485 quality management compliance.
Manufacturer claims HCCL™ manufacturing minimizes residual BDDE and delivers a stabilized 3D matrix (manufacturer technical claims in brochure).
CE certified (manufacturer brochure explicitly states CE certification for the TEOFIL family; brochure indicates compliance with medical device regulations for CE marking).
Manufacturer states ISO 13485 quality management compliance.
Manufacturer claims HCCL™ manufacturing minimizes residual BDDE and delivers a stabilized 3D matrix (manufacturer technical claims in brochure).
Clinical trial summary included in manufacturer brochure indicating comparative testing vs. reference device (brochure pages summarise clinical/efficacy assessments).
Monophasic HA dermal filler for deep dermis / subcutaneous volumising (contouring)
Description
TEOFIL Sub-Q is a CE-certified, monophasic cross-linked hyaluronic acid (HA) filler manufactured using HCCL™ (Highly Completed Cross-Linking) technology. Formulated as a high-viscosity, viscoelastic gel for deep dermal and subcutaneous placement, Sub-Q is designed to restore lost facial volume and enhance contours in areas such as the chin, jawline and cheeks. The product is supplied in a prefilled syringe (1.1 ml) and includes lidocaine (0.3%) to increase patient comfort during injection. Manufacturer product literature states CE classification as a Class III medical device and lists composition, recommended injection depth and pack contents.
Bnefits
High-viscosity monophasic gel providing structural support for facial contouring (chin, jawline, cheeks)
HCCL™ advanced cross-linking manufacturing process claimed to improve stability and minimize pendant BDDE
Contains lidocaine (0.3%) for reduced injection discomfort
20 mg HA per ml concentration for volumising and hydration
Supplied as a ready-to-use prefilled syringe with recommended needle gauges for clinical use
CE marked (manufacturer-stated) and produced under ISO 13485 quality processes per manufacturer literature
Indications
Enhancement of facial contours and restoration of lost volume (chin, jawline, cheeks)
Volumising applications requiring durable structural support via medium-to-deep/subcutaneous placement
General facial contouring where a high-viscosity HA filler is clinically indicated
Clinical trial summary included in manufacturer brochure indicating comparative testing vs. reference device (brochure pages summarise clinical/efficacy assessments).
Monophasic hyaluronic acid gel with enhanced viscoelasticity for deep/subcutaneous injection
Prefilled sterile syringe (1.1 ml) intended for single use
Pack includes recommended needle gauges (manufacturer product summary lists 1 x 25G needle and 1 x 27G needle for Sub-Q)
Packaging
Typically supplied as 1 x 1.1 ml prefilled syringe in sterile single-use packaging (manufacturer brochure / distributor listings)
Individual syringe packaged with needles and product leaflet; carton and artwork may vary by region and distributor
Usage
For professional use only by qualified practitioners trained in injectable dermal fillers (manufacturer/distributor pages state 'Professional Use Only').
Use aseptic technique and follow the manufacturer's instructions for injection depth and technique (Sub-Q is intended for deep dermal to subcutaneous/periosteal placement).
Select appropriate needle/cannula size as recommended in product literature; manufacturer lists 25G and 27G needles in pack contents for Sub-Q.
Inspect packaging integrity prior to use; follow local protocols for patient selection, informed consent, and post-procedure care.
Follow local sharps disposal and infection-control procedures and monitor patients for adverse events post-injection.
Contraindications
Not publicly listed
Adverse Effects
Not publicly listed
Storage Conditions
Manufacturer/distributor materials reference standard storage in original packaging, protected from extreme temperatures and direct sunlight; consult product labelling/IFU for exact temperature range.
Keep sterile until use and store in a clean, dry place as indicated on carton/leaflet.
Duration
Not publicly listed (manufacturer/distributor materials describe 'long-lasting' results; no fixed duration guarantee is published \u2014 clinical duration depends on individual factors and is variable)
Onset
Not publicly listed (immediate visible volumising/smoothing effect expected upon injection; brochure does not quantify onset time)
